<DOC>
<DOCNO>EP-0645138</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Pharmaceutical composition for maintaining and/or reestablishing a rate of blood platelet aggregation clone to the normal value.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K902	A61K902	A61K908	A61K908	A61K9107	A61K9107	A61K914	A61K914	A61K920	A61K920	A61K31185	A61K31195	A61K31198	A61K3121	A61K3122	A61K3144	A61K3144	A61P700	A61P702	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	A61K9	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P7	A61P7	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to a pharmaceutical composition which can be administered to man or animals, for maintaining and/or reestablishing a rate of blood platelet aggregation close to the normal value, which comprises cysteine and/or cystine and/or their derivatives at a dose and in a form which are physiologically acceptable.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
DEHORNE MARTHE
</APPLICANT-NAME>
<APPLICANT-NAME>
DEHORNE, MARTHE
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DEHORNE MARTHE
</INVENTOR-NAME>
<INVENTOR-NAME>
DEHORNE, MARTHE
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
